Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Pichler

Showing results (261-270 of 306) with videos related to

Pageof 31
Sort By:
Annals of Surgical Oncology|October 10, 2023
Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy EraLukas Scheipner, Francesco Barletta, Cristina Cano Garcia, et al.
Cancers|August 23, 2020
C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center StudyJakob M Riedl, Dominik A Barth, Wolfgang M Brueckl, et al.
Breast Cancer Research : BCR|February 3, 2019
MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitorsDaniela Schwarzenbacher, Christiane Klec, Barbara Pasculli, et al.
Genome Medicine|April 9, 2013
Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencingEllen Heitzer, Peter Ulz, Jelena Belic, et al.
Non-Coding RNA|June 20, 2019
The <i>Non-Coding RNA</i> Journal Club: Highlights on Recent Papers-7Hua Xiao, Patrick K T Shiu, Marta Gabryleska, et al.
Thrombosis and Haemostasis|July 13, 2021
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-PaclitaxelJakob M Riedl, Esther Schwarzenbacher, Florian Moik, et al.
Frontiers in Immunology|April 18, 2022
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer StudyDominik A Barth, Stefanie Stanzer, Jasmin A Spiegelberg, et al.
Oncotarget|November 23, 2017
IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancerSonja M Kessler, Eva Lederer, Stephan Laggai, et al.
Oncotarget|April 21, 2017
Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAsMohammed H Rashed, Pinar Kanlikilicer, Cristian Rodriguez-Aguayo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 23, 2018
Surgery for metachronous metastasis of soft tissue sarcoma - A magnitude of benefit analysis using propensity score methodsMaria A Smolle, Veroniek M van Praag, Florian Posch, et al.
Pageof 31

Showing results (261-270 of 306) with videos related to

Sort By:
Pageof 31
Annals of Surgical Oncology|October 10, 2023
Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy EraLukas Scheipner, Francesco Barletta, Cristina Cano Garcia, et al.
Cancers|August 23, 2020
C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center StudyJakob M Riedl, Dominik A Barth, Wolfgang M Brueckl, et al.
Breast Cancer Research : BCR|February 3, 2019
MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitorsDaniela Schwarzenbacher, Christiane Klec, Barbara Pasculli, et al.
Genome Medicine|April 9, 2013
Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencingEllen Heitzer, Peter Ulz, Jelena Belic, et al.
Non-Coding RNA|June 20, 2019
The <i>Non-Coding RNA</i> Journal Club: Highlights on Recent Papers-7Hua Xiao, Patrick K T Shiu, Marta Gabryleska, et al.
Thrombosis and Haemostasis|July 13, 2021
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-PaclitaxelJakob M Riedl, Esther Schwarzenbacher, Florian Moik, et al.
Frontiers in Immunology|April 18, 2022
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer StudyDominik A Barth, Stefanie Stanzer, Jasmin A Spiegelberg, et al.
Oncotarget|November 23, 2017
IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancerSonja M Kessler, Eva Lederer, Stephan Laggai, et al.
Oncotarget|April 21, 2017
Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAsMohammed H Rashed, Pinar Kanlikilicer, Cristian Rodriguez-Aguayo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 23, 2018
Surgery for metachronous metastasis of soft tissue sarcoma - A magnitude of benefit analysis using propensity score methodsMaria A Smolle, Veroniek M van Praag, Florian Posch, et al.
Pageof 31